AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Profit After Tax History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit After Tax | ₹1,928 Cr | ₹2,647 Cr | ₹5,334 Cr | ₹2,844 Cr | ₹2,365 Cr |
What is the latest Profit After Tax of AUROBINDO PHARMA ?
Year | Profit After Tax |
---|---|
Mar2024 | ₹1,928 Cr |
Mar2023 | ₹2,647 Cr |
Mar2022 | ₹5,334 Cr |
Mar2021 | ₹2,844 Cr |
Mar2020 | ₹2,365 Cr |
How is Profit After Tax of AUROBINDO PHARMA Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹1,928 Cr | -27.18 | |
Mar2023 | ₹2,647 Cr | -50.37 | |
Mar2022 | ₹5,334 Cr | 87.57 | |
Mar2021 | ₹2,844 Cr | 20.27 | |
Mar2020 | ₹2,365 Cr | - |
Compare Profit After Tax of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹68,409.5 Cr | 1.4% | -5.6% | 0.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,557.0 Cr | 2.3% | -0.8% | 32.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,994.0 Cr | 3.2% | 1.1% | 51.5% | Stock Analytics | |
CIPLA | ₹116,494.0 Cr | 0.3% | -2% | 10% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,297.0 Cr | -1.8% | 2.7% | 12.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,035.0 Cr | 2% | 1.5% | 38% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 1.4% |
-5.6% |
0.6% |
SENSEX | -1% |
-5% |
5.6% |
You may also like the below Video Courses